751 - 800 of 6570 Results
Title
Year
-
OPENTitle: Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease [RETIRED]Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 6Start Page: 597End Page: 603Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318263c443Best OA location URL: https://n.neurology.org/content/neurology/79/6/597.full.pdfCitation Count: 177
-
OPENTitle: Naltrexone for impulse control disorders in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 83Issue #: 9Start Page: 826End Page: 833Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000000729Best OA location URL: https://n.neurology.org/content/neurology/83/9/826.full.pdfCitation Count: 96
-
OPENTitle: Physician response to a medication alert system in inpatients with levodopa-treated diseasesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 85Issue #: 5Start Page: 420End Page: 424Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001745Best OA location URL: https://n.neurology.org/content/neurology/85/5/420.full.pdfCitation Count: 7
-
OPENTitle: Cognitive performance of GBA mutation carriers with early-onset PDJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 18Start Page: 1434End Page: 1440Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318253d54bBest OA location URL: https://n.neurology.org/content/neurology/78/18/1434.full.pdfCitation Count: 268
-
OPENTitle: Neurologist-associated reduction in PD-related hospitalizations and health care expendituresJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 17Start Page: 1774End Page: 1780Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182703f92Best OA location URL: https://n.neurology.org/content/neurology/79/17/1774.full.pdfCitation Count: 106
-
OPENTitle: On the fallacy of quantitative segmentation for T1-weighted MRIJournal Name: SPIE ProceedingsPublisher: SPIEVol: 9784Issue #:Start Page: 978416End Page: 978416Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1117/12.2216994Best OA location URL: http://doi.org/10.1117/12.2216994Citation Count: 5
-
OPENTitle: Proteomic Analysis of Alzheimers Disease Cerebrospinal Fluid from Neuropathologically Diagnosed SubjectsJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 6Issue #: 4Start Page: 399End Page: 406Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/156720509788929318Best OA location URL: http://www.eurekaselect.com/article/29748Citation Count: 34
-
OPENTitle: Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's DiseaseJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 14Issue #: 6Start Page: 578End Page: 585Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1567205014666170203093219Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6091859Citation Count: 16
-
OPENTitle: Association Studies of Sporadic Parkinson’s Disease in the Genomic EraJournal Name: Current GenomicsPublisher: Bentham Science Publishers Ltd.Vol: 15Issue #: 1Start Page: 2End Page: 10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1389202914666131210212745Best OA location URL: http://www.eurekaselect.com/article/57972Citation Count: 28
-
OPENTitle: Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathologyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 139Issue #:Start Page: 104810End Page: 104810Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104810Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104810Citation Count: 38
-
OPENTitle: Assessment of LIN28A variants in Parkinson's disease in large European cohortsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 100Issue #:Start Page: 118.e1End Page: 118.e3Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.12.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7920911Citation Count: 6
-
OPENTitle: The LRR-Roc-COR module of theChlorobium tepidumRoco protein: crystallization and X-ray crystallographic analysisJournal Name: Acta Crystallographica Section F Structural Biology CommunicationsPublisher: International Union of Crystallography (IUCr)Vol: 73Issue #: 9Start Page: 520End Page: 524Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1107/s2053230x17011955Best OA location URL: http://journals.iucr.org/f/issues/2017/09/00/wd5279/wd5279.pdfCitation Count: 9
-
OPENTitle: Novel method to ascertain chromatin accessibility at specific genomic loci from frozen brain homogenates and laser capture microdissected defined cellsJournal Name: NeuroepigeneticsPublisher: Elsevier BVVol: 6Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nepig.2016.03.001Best OA location URL: https://doi.org/10.1016/j.nepig.2016.03.001Citation Count: 0
-
OPENTitle: Distinct alterations in Parkinson's medication-state and disease-state connectivityJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 16Issue #:Start Page: 575End Page: 585Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.09.004Best OA location URL: https://doi.org/10.1016/j.nicl.2017.09.004Citation Count: 48
-
OPENTitle: Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1632End Page: 1642Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27404Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27404Citation Count: 16
-
OPENTitle: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 1SStart Page: S62End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011Best OA location URL: http://doi.org/10.1016/j.jalz.2013.12.011Citation Count: 70
-
OPENTitle: The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and functionJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 156Issue #:Start Page: 113896End Page: 113896Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.biopha.2022.113896Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113896Citation Count: 14
-
OPENTitle: Spring is in the air: seasonal profiles indicate vernal change of miRNA activityJournal Name: RNA BiologyPublisher: Informa UK LimitedVol: 16Issue #: 8Start Page: 1034End Page: 1043Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15476286.2019.1612217Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15476286.2019.1612217?needAccess=trueCitation Count: 17
-
OPENTitle: Inhibition of autophagic flux by S-nitrosylation of SQSTM1/p62 promotes neuronal secretion and cell-to-cell transmission of SNCA/α-synuclein in Parkinson disease and Lewy body dementiaJournal Name: Autophagy ReportsPublisher: Informa UK LimitedVol: 1Issue #: 1Start Page: 223End Page: 225Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/27694127.2022.2076770Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/27694127.2022.2076770?needAccess=trueCitation Count: 7
-
OPENTitle: Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 3End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.001Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6589361Citation Count: 28
-
OPENTitle: Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal systemJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 48Issue #: 1Start Page: 9End Page: 19Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.06.005Best OA location URL: https://doaj.org/article/51752686f9774ce2aae93abfd8ee862eCitation Count: 81
-
OPENTitle: Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessmentsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 12Issue #:Start Page: e1End Page: e9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2016.02.012Best OA location URL: https://doi.org/10.1016/j.nicl.2016.02.012Citation Count: 82
-
OPENTitle: Lack of evidence for association of UQCRC1 with Parkinson's disease in EuropeansJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 101Issue #:Start Page: 297.e1End Page: 297.e4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.030Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8938960Citation Count: 14
-
OPENTitle: Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau ProtofibrilsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 18Start Page: 3528End Page: 3539Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.3c00437Best OA location URL: https://doi.org/10.1021/acschemneuro.3c00437Citation Count: 22
-
OPENTitle: mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cellsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 12Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.038596Best OA location URL: https://doi.org/10.1242/dmm.038596Citation Count: 74
-
OPENTitle: Lack of epistatic interaction of SNCA with APOE in synucleinopathiesJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 6Start Page: fcaf455End Page: fcaf455Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf455Best OA location URL: https://doi.org/10.1093/braincomms/fcaf455Citation Count: 1
-
OPENTitle: Lewy pathology largely absent in prefrontal cortices of Parkinson’s disease patients undergoing deep brain stimulationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1038/s41531-026-01422-8Best OA location URL: https://www.nature.com/articles/s41531-026-01422-8.pdfCitation Count: 0
-
OPENTitle: BDNF polymorphism associates with decline in set shifting in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 3Start Page: 1605.e1End Page: 1605.e6Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.08.023Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0197458014005363Citation Count: 47
-
OPENTitle: Deep Brain Stimulation in a Case of Mitochondrial DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 3Issue #: 2Start Page: 139End Page: 145Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12241Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12241Citation Count: 12
-
OPENTitle: Feasibility, Safety, and Compliance in a Randomized Controlled Trial of Physical Therapy for Parkinson's DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/795294Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/795294.pdfCitation Count: 33
- Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia2021OPENTitle: Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementiaJournal Name: CortexPublisher: Elsevier BVVol: 139Issue #:Start Page: 99End Page: 115Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2021.03.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8119343Citation Count: 39
-
OPENTitle: Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodentsJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 522Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.23612Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cne.23612Citation Count: 4
-
OPENTitle: Multi-cohort, cross-species urinary proteomics reveals signatures of LRRK2 dysfunction in Parkinson’s diseaseJournal Name: Molecular Systems BiologyPublisher: Springer Science and Business Media LLCVol: 22Issue #: 5Start Page: 712End Page: 737Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s44320-026-00190-0Best OA location URL: https://link.springer.com/content/pdf/10.1038/s44320-026-00190-0.pdfCitation Count: 2
-
OPENTitle: Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 107Issue #: 3Start Page: 553End Page: 562Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.1634Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7939141Citation Count: 19
-
OPENTitle: Multimodal MRI evaluation of parkinsonian limbic pathologiesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 76Issue #:Start Page: 194End Page: 200Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.01.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6461740Citation Count: 15
-
OPENTitle: Intact working memory in non‐manifesting LRRK2 carriers – an fMRI studyJournal Name: European Journal of NeurosciencePublisher: WileyVol: 43Issue #: 1Start Page: 106End Page: 112Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.13120Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13120Citation Count: 20
-
OPENTitle: Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 69Issue #:Start Page: 263End Page: 275Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.05.012Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4135465Citation Count: 34
- Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse Model2023OPENTitle: Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse ModelJournal Name: Annals of NeurologyPublisher: WileyVol: 93Issue #: 5Start Page: 881End Page: 892Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26600Citation Count: 15
-
OPENTitle: Holmes Tremor‐Like Phenotype in DYT1 DystoniaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 206End Page: 208Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12585Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12585Citation Count: 3
-
OPENTitle: Exploring the layers of fatigue in Parkinson’s Disease: A comprehensive analysis of its prevalence and contributing factorsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 11Issue #:Start Page: 100288End Page: 100288Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100288Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100288Citation Count: 3
-
OPENTitle: Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson’s disease patients with defined cholinergic lossesJournal Name: NeuroImagePublisher: Elsevier BVVol: 149Issue #:Start Page: 295End Page: 304Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.02.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5386784Citation Count: 50
-
OPENTitle: Essential Tremor and DepressionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 6Start Page: 838End Page: 842Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12530Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12530Citation Count: 13
-
OPENTitle: Stimulation-induced reversed plus-minus syndrome: Insights into eyelid physiologyJournal Name: Brain StimulationPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 951End Page: 952Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2018.04.010Best OA location URL: https://doaj.org/article/b711f7d9567240b89145b894bc21f1beCitation Count: 3
-
OPENTitle: Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervationJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 123Issue #: 4Start Page: 421End Page: 424Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-016-1524-7Best OA location URL: http://doi.org/10.1007/s00702-016-1524-7Citation Count: 30
-
OPENTitle: Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacyJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 12Start Page: 2915End Page: 2919Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.04.041Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4899947Citation Count: 3
-
OPENTitle: Combating Parkinson’s disease-associated toxicity by modulating proteostasisJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 114Issue #: 5Start Page: 803End Page: 804Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1620082114Best OA location URL: https://www.pnas.org/content/pnas/114/5/803.full.pdfCitation Count: 6
-
OPENTitle: Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: Gene and smoking status interactionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 72End Page: 76Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.07.007Best OA location URL: https://zenodo.org/record/3421671Citation Count: 28
-
OPENTitle: Glucagon‐like Peptides (GLP‐1) Perspectives in Synucleinopathies TreatmentJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 3Start Page: 255End Page: 258Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12611Citation Count: 7
-
OPENTitle: Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetesJournal Name: Pharmacoepidemiology and Drug SafetyPublisher: WileyVol: 31Issue #: 8Start Page: 875End Page: 882Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/pds.5448Best OA location URL: https://doi.org/10.1002/pds.5448Citation Count: 19
-
OPENTitle: Effect of the mGlu2 receptor positive allosteric modulator AZD8529 on L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmosetJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 1005Issue #:Start Page: 178031End Page: 178031Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ejphar.2025.178031Best OA location URL: https://doi.org/10.1016/j.ejphar.2025.178031Citation Count: 0